Dai L, Winyard P G, Zhang Z, Blake D R, Morris C J
Inflammation Research Group, St Bartholomew's School of Medicine and Dentistry, London, UK.
Biochim Biophys Acta. 1996 Dec 13;1304(3):223-8. doi: 10.1016/s0005-2760(96)00121-x.
Whilst catalytic iron has been implicated in the development of atherosclerosis by initiating low density lipoprotein (LDL) oxidation, the source of such iron remains uncertain. Here, we show that LDL oxidation in the presence of ferritin was stimulated by ascorbate (15-60 microM), whilst this effect was inhibited by the iron chelator desferrioxamine. Ascorbate also showed an antioxidant activity at high concentrations (125-250 microM). Our results suggest that the combination of ascorbate with ferritin may supply free iron for LDL oxidation in vivo.